Scientists are testing an experimental anti-amyloid antibody in people expected to develop early-onset Alzheimer's.

Years before tau tangles show up in brain scans of patients with Alzheimer's disease, a biomarker test developed at the ...

Researchers say CSF biomarker test correlates with the severity of cognitive decline, independent of other factors, including brain amyloid deposition.

Research supporting the amyloid hypothesis—the idea that Alzheimer's is caused by a buildup of amyloid plaques in the ...

There is no cure. Between 1995 and 2021, around $42bn was poured into more than 1,000 clinical trials. Yet only a handful of ...

Drugs targeting amyloid plaques have failed to show efficacy in clinical trials. A new approach is needed to tackle AD ...

Readers worry that fraud may tarnish the field and slow the race for a cure. Also: Charles Blow’s farewell; treatment for ...

The finding may open a whole new world in the study of Alzheimer's disease, said biophysicist Aneta Stefanovska.

A new biomarker test developed at the University of Pittsburgh could help doctors doctors detect signs of Alzheimer's years sooner, according to research published Monday in Nature Medicine.

Regular aerobic exercise was linked to a reduction in markers in the brains of in rats that associated with the onset of Alzheimer's, including amyloid plaques, according to a new paper in the ...

The first participants in an international clinical trial aimed at preventing Alzheimer’s disease in young adults at high ...

These results hint at yet another insidious effect of COVID, the researchers write, suggesting even mild or moderate cases might speed up biological processes promoting the accumulation of beta ...